IDXX
$529.01 · +1.7% today · +4.4% 5d · −8.2% 3m · −16.5% 1y
Daily score99
Weekly score94
Long-term score20
Close
Scores (0–100)
Components — latest (2026-10-14)
Close
529.01
1D return
+1.7%
5D return
+4.4%
Rel volume
1.63
CMF 20
0.20
OBV slope 20
0.38
Up-vol ratio 10
0.63
Short ratio
0.52
Short ratio Δ
+2.3%
Persistence 10
7.00
Inflow mean 5d
0.87
Inflow mean 60d
0.07
Momentum 12-1
−19.4%
% of 52w high
+69.0%
vs 200d
−8.9%
Volatility 60d
+24.6%
Dollar vol 20d
$273.60M
Insider buys 90d
$0
Insider buyers 90d
0.00
Revenue growth
+9.7%
Fundamentals — Idexx Laboratories · Health Care
as of 2026-10-22- P/E
- 42.1
- P/B
- 27.69
- ROE
- 65.7%
- Operating margin
- 31.6%
- Debt / equity
- 0.19
- FCF yield
- 2.4%
- Years profitable
- 5/5
- BM score
- 64
- Moat flag
- Yes
Insider trades (Form 4)
| Filed | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-09 | Kingsley Lawrence D | Director | Sell | 2.2K | $532.08 | $1.17M |
Congress trades
| Filed | Traded | Member | Type | Owner | Amount | Lag | Source |
|---|---|---|---|---|---|---|---|
| 2026-02-02 | 2026-01-13 | April McClain Delaney (MD06) | Sale | Dependent child | $1,001 - $15,000 | 20 | |
| 2025-11-04 | 2025-10-16 | April McClain Delaney (MD06) | Sale (partial) | Dependent child | $1,001 - $15,000 | 19 |
Source: U.S. House Clerk periodic transaction reports (STOCK Act). Disclosures lag trades.